CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via JAK2/STAT3 pathway

Canhui Cao1, Miaochun Xu2, Ye Wei1

  • 1Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430199, China; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.

Cell Genomics
|September 24, 2024
PubMed

Insights

CXCR4 antagonists can improve cancer immunotherapy. This study reveals CXCR4 drives T-cell exhaustion, and blocking it restores immune function, supporting combination therapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Medicine

Background:

  • Clinical trials indicate CXCR4 antagonists enhance cancer immunotherapy.
  • The precise mechanisms of CXCR4's role in immune cell phenotypes remain unclear.

Purpose of the Study:

  • To elucidate the role of CXCR4 in CD8+ T-cell exhaustion.
  • To investigate the mechanistic pathways regulated by CXCR4 in T-cells.
  • To provide a rationale for CXCR4 antagonist combination therapy.

Main Methods:

  • Single-cell transcriptomic analysis (scRNA-seq).
  • In vivo experiments blocking CXCR4.
  • Single-cell RNA/TCR/ATAC-seq.
  • Clinical sample analysis.

Main Results:

  • CXCR4 is a marker gene in T-cells, highly expressed in exhausted CD8+ T (Tex) cells.
  • Blocking CXCR4 in vivo attenuated the Tex phenotype.
  • CXCR4 blockade modulated the JAK2-STAT3 pathway.
  • Cxcr4-deficient CD8+ T-cells showed epigenetic mitigation of exhaustion.
  • Increased CXCR4+CD8+ T-cells correlated with non-complete pathological response in patients.

Conclusions:

  • CXCR4 orchestrates the CD8+ Tex cell phenotype.
  • CXCR4 antagonists can reverse T-cell exhaustion via the JAK2-STAT3 pathway.
  • These findings support combining CXCR4 antagonists with immunotherapy for enhanced efficacy.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
858
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
960
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
686